Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Cell Mol Biol (Noisy-le-grand) ; 56 Suppl: OL1318-23, 2010 Jun 15.
Artigo em Inglês | MEDLINE | ID: mdl-20937218

RESUMO

The Trypanosoma cruzi parasite is an etiologic agent of the American trypanosomiasis called Chagas disease. This pathology affects more than 24 million persons and represents one of the most important public health problems in Latin America. Taking into account this, it is necessary the search of new antitrypanosomal agents that show a major level of efficacy and minor indexes of toxicity in affected patients. Vast source of them are the natural products from plants with enormous structural diversity. A particular type of these compounds is represented by aporphinoid alkaloids. In our experiments, anonaine (2), oliverine (3) and guatterine (5) displayed antitrypanosomal activity. The compound 3 showed the most important activity with an IC50 = 12.00 ± 0.36 μM. Its mechanism of action may include inhibition of DNA synthesis.


Assuntos
Alcaloides/farmacologia , DNA de Protozoário/biossíntese , Tripanossomicidas/farmacologia , Alcaloides/química , DNA de Protozoário/efeitos dos fármacos , Tripanossomicidas/química , Trypanosoma cruzi/efeitos dos fármacos
2.
Protein Expr Purif ; 22(2): 225-33, 2001 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-11437598

RESUMO

The P0 protein is part of the ribosomal eukaryotic stalk, which is an elongated lateral protuberance of the large ribosomal subunit involved in the translocation step of protein synthesis. P0 is the minimal portion of the stalk that is able to support accurate protein synthesis. The P0 C-terminal peptide is highly antigenic and a major target of the antibody response in patients with systemic lupus erythematosus and patients suffering chronic heart disease produced by the Trypanosoma cruzi parasite. The T. cruzi P0 (TcP0) protein was cloned into the pRSET A vector and expressed in Escherichia coli fused to a His-tag. The identity of the protein was confirmed by immunoblotting. Due to the formation of inclusion bodies the protein was purified using the following steps: (i) differential centrifugation to separate the inclusion bodies from soluble proteins and (ii) affinity chromatography under denaturing conditions. TcP0 showed high tendency to aggregation during refolding assays. However, TcP0 could be efficiently folded in the presence of a low concentration of SDS. The folding of the protein was confirmed using urea gradient electrophoresis, limited proteolysis, circular dichroism, and tryptophan fluorescence. Native electrophoresis showed that the folded TcP0 (and not a folding intermediate) was the cause of aggregation in the absence of SDS. The protocol described here permitted us to obtain large amounts (up to 30 mg per culture liter) of pure and folded TcP0, a very hydrophobic protein with a high tendency to aggregation.


Assuntos
Fosfoproteínas/química , Fosfoproteínas/genética , Dobramento de Proteína , Proteínas de Protozoários/química , Proteínas de Protozoários/genética , Proteínas Ribossômicas/química , Proteínas Ribossômicas/genética , Trypanosoma cruzi/química , Animais , Dicroísmo Circular , Vetores Genéticos , Substâncias Macromoleculares , Fosfoproteínas/biossíntese , Conformação Proteica , Desnaturação Proteica , Estrutura Secundária de Proteína , Proteínas de Protozoários/biossíntese , Proteínas de Protozoários/isolamento & purificação , Proteínas Recombinantes de Fusão/biossíntese , Proteínas Recombinantes de Fusão/genética , Proteínas Recombinantes de Fusão/isolamento & purificação , Proteínas Ribossômicas/biossíntese , Proteínas Ribossômicas/isolamento & purificação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...